about
Early cell death detection with digital holographic microscopySimultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometryRibavirin: Past, present and futureAnti-hepatitis C virus drugs and kidneyReal-time dual-wavelength digital holographic microscopy with a single hologram acquisitionContribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomesEffects of hypotonic stress and ouabain on the apparent diffusion coefficient of water at cellular and tissue levels in Aplysia.Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.Comparative study of human erythrocytes by digital holographic microscopy, confocal microscopy, and impedance volume analyzer.Spatially-resolved eigenmode decomposition of red blood cells membrane fluctuations questions the role of ATP in flickeringModeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings.Digital holographic microscopy: a noninvasive contrast imaging technique allowing quantitative visualization of living cells with subwavelength axial accuracy.Polarization microscopy by use of digital holography: application to optical-fiber birefringence measurements.Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry.Purely numerical compensation for microscope objective phase curvature in digital holographic microscopy: influence of digital phase mask position.Submicrometer optical tomography by multiple-wavelength digital holographic microscopy.Amplitude point-spread function measurement of high-NA microscope objectives by digital holographic microscopy.Determination of three beta-blockers in biofluids and solid tissues by liquid chromatography-electrospray-mass spectrometry.Measurement of the integral refractive index and dynamic cell morphometry of living cells with digital holographic microscopy.Total aberrations compensation in digital holographic microscopy with a reference conjugated hologram.Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry.Cell morphology and intracellular ionic homeostasis explored with a multimodal approach combining epifluorescence and digital holographic microscopy.Recognition and classification of red blood cells using digital holographic microscopy and data clustering with discriminant analysis.Pesticide contamination of workers in vineyards in France.Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.High b-value diffusion-weighted imaging: a sensitive method to reveal white matter differences in schizophrenia.Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry.Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays.Label-free cytotoxicity screening assay by digital holographic microscopyIs LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?Simultaneous optical recording in multiple cells by digital holographic microscopy of chloride current associated to activation of the ligand-gated chloride channel GABA(A) receptor.Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients.Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoringPopulation pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part IMeasurement of absolute cell volume, osmotic membrane water permeability, and refractive index of transmembrane water and solute flux by digital holographic microscopy.Living specimen tomography by digital holographic microscopy: morphometry of testate amoeba.Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
P50
Q21135059-C8E760A8-237D-4BAF-97AC-4161FCA57ECEQ24321356-6A210E97-D391-43D2-A4DC-D9348B1F5DA3Q26775002-1806A8D9-5801-4696-BCDA-03761E75431EQ28070279-D411EFC3-B220-416D-A144-13769EE76BA3Q28249528-449F0FBD-B4AA-46D0-96CB-8DC84CE818EEQ28261843-7E81F131-389A-4FA7-8396-227EC3839102Q30729171-C0F18AC1-5B2D-4BDE-920D-496372909E39Q30827623-816E7D3B-2F3D-47D7-B2BB-52CFC161CC8FQ30845004-4B9BF809-1ACF-4288-B07C-01EB9C47BAB9Q31085755-6C700B82-ECD2-47AA-A62C-AA57349C514FQ31120605-8EC0EA68-0D8E-4890-9436-5774E3E80861Q31153598-9A2762D3-F8B8-43D5-ACFC-5E7992B09BDEQ33213199-655FC1CE-816F-4040-AC45-AD37625D8C42Q33220439-8566F374-5C39-4188-B589-6FAF93985AEDQ33251285-19F07308-2BD0-472B-82C1-3F5D60AD2F21Q33260674-420409C1-E165-49D5-92DB-C98BDDB5349EQ33261745-75DCDFA0-1E85-4E6B-9956-F9646FA168DDQ33294275-CC6182E9-D752-47E6-B00E-3CA5C2D8B250Q33432480-1ABD621A-4322-4EDB-8138-14D1844E8F30Q33462718-C8BAE1FD-E0A1-49D6-8D38-9B19D69AC63CQ33465725-0504F1F9-9B6C-43BD-B0D2-A4A7945B5E92Q33530334-D9B8599A-FD3E-4AB3-9E64-71E1E7CDB8B0Q33543867-FBC8A901-A7AA-4D5C-A475-7B886F443FC6Q33923933-C7AB429F-00DD-4C90-A540-A5C5B75B313CQ33990208-F78886F2-8708-4ADB-82E4-186D473448A4Q34077882-478C8F75-8206-4424-8451-0F7F1AE712B3Q34183625-B2F39B8F-56B8-45E2-B397-B79119BE9B91Q34248526-B5CF4FE1-A5E6-42C5-ABD5-C5B02FAE1CD6Q34287623-4B345F22-8009-46BF-AFEE-BC8C69A8F5A4Q34327708-C16808E1-B9CA-4D14-8902-2760F6473572Q34444528-22511AB5-845C-4DDA-A1A3-0E9999CCB58EQ34503331-A9E7D595-5561-4BDC-B221-1509C4FDD50AQ34510689-5E29792E-2A7B-48BC-B5F7-92B754CF9FDCQ34554442-5136A466-F8FD-4840-98EC-CE8D42951660Q34554467-E15061CF-F224-43A2-8BEC-89F6F90EFAF8Q34609009-054C3D8D-C722-4807-AA21-42E06553B570Q34610933-3447ADC3-DBD5-41CA-8E13-2EC89BDB521DQ34619779-9AE909D6-545F-4FC9-8DA2-893A3F57C839Q34987036-F84A6B65-7525-4C22-B8EE-041BCBB5870FQ35012176-AF7196DB-76B3-4350-9DE7-A5DDEDD4229A
P50
description
chercheur et professeur à l'Université Laval
@fr
researcher and professor at Université Laval
@en
name
Pierre Marquet
@ast
Pierre Marquet
@en
Pierre Marquet
@es
Pierre Marquet
@fr
Pierre Marquet
@nl
type
label
Pierre Marquet
@ast
Pierre Marquet
@en
Pierre Marquet
@es
Pierre Marquet
@fr
Pierre Marquet
@nl
prefLabel
Pierre Marquet
@ast
Pierre Marquet
@en
Pierre Marquet
@es
Pierre Marquet
@fr
Pierre Marquet
@nl
P269
P108
P1153
57197861742
P2038
Pierre_Marquet
P21
P214
101157098584572552695